| Active substance | Gliclazide  | 
		
|---|---|
| Storage conditions | Store at room temperature away from moisture and heat  | 
		
| Side effects | Hypoglycemia, gastrointestinal disturbances (e.g., nausea, indigestion), dizziness, headache  | 
		
| Effects | Lowers blood glucose levels by stimulating insulin release from pancreatic beta cells  | 
		
| Dosage (sports) | Not applicable  | 
		
| Dosage (medical) | Typically 40-120 mg per day, depending on patient response and formulation (immediate or extended release)  | 
		
| Half-life | 10-12 hours  | 
		
| Main action | Hypoglycemic agent  | 
		
| Substance class | Sulfonylurea  | 
		
| Formula | C15H21N3O3S  | 
		
| Chemical name | 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea  | 
		
| Trade name | Diamicron, among others  | 
		
| Blood pressure | No significant impact on blood pressure  | 
		
| WAREHOUSE | International Warehouse 2  | 
		
| Also known as | Glyclazide  | 
		
| Lab Test | Blood glucose monitoring, hemoglobin A1c  | 
		
| Aromatization | No  | 
		
| Hepatotoxicity | No  | 
		
| HBR | No  | 
		
| Water Retention | No  | 
		
| Acne | No  | 
		
| Use in sports | Not typically used in sports  | 
		
| Manufacturer | Servier  | 
		






There are no reviews yet.